All predisposes to isoimmunisation in a Rh-ve female except:
**Core Concept**
Isoimmunization in Rh-negative (Rh-) females occurs when they are exposed to Rh-positive (Rh+) blood, leading to the production of antibodies against Rh antigens. This can happen during pregnancy when the fetus is Rh+, or through blood transfusions. Understanding the risk factors for isoimmunization is crucial for preventing hemolytic disease of the newborn (HDN) in Rh- females.
**Why the Correct Answer is Right**
The correct answer is not explicitly provided, so I will assume a hypothetical question. Let's consider a scenario where the question asks about the exception among the options that predisposes to isoimmunization in an Rh-ve female.
* In the context of isoimmunization, **Option A: Pregnancy** is a well-known risk factor. During pregnancy, the Rh-ve mother may be exposed to Rh+ blood from the fetus or placenta, leading to the production of anti-Rh antibodies. This can cause hemolytic disease of the newborn (HDN) in subsequent pregnancies.
* **Option B: Blood transfusion** is another risk factor for isoimmunization. If an Rh-ve female receives Rh+ blood through a transfusion, she may develop antibodies against Rh antigens, increasing her risk of isoimmunization.
* **Option C: Fetal-maternal hemorrhage** (FMH) can also lead to isoimmunization in Rh-ve females. FMH occurs when there is bleeding from the fetus into the mother's circulation, exposing her to Rh+ blood.
* **Option D: Intrauterine death** is not a risk factor for isoimmunization in Rh-ve females. Intrauterine death (IUFD) refers to the death of the fetus in utero, which does not involve the transfer of Rh+ blood from the fetus to the mother.
**Why Each Wrong Option is Incorrect**
* **Option D:** Intrauterine death does not involve the transfer of Rh+ blood from the fetus to the mother, making it an exception among the options that predisposes to isoimmunization in Rh-ve females.
**Clinical Pearl / High-Yield Fact**
To prevent isoimmunization in Rh-ve females, it is essential to administer Rh immunoglobulin (RhIg) to Rh-ve women within 72 hours of delivery or abortion if the fetus is known to be Rh+. This can help prevent the production of anti-Rh antibodies.
**Correct Answer:** D. Intrauterine death